The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
650
ORAL OMILANCOR TREATMENT OUTPERFORMS ANTI-TL1A THERAPEUTICS IN IBD
Date
May 5, 2025
Explore related products in the following collection:
